These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 28151504)

  • 41. Antiphospholipid Antibodies in Lupus Nephritis.
    Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmström V; Svenungsson E; Gunnarsson I
    PLoS One; 2016; 11(6):e0158076. PubMed ID: 27336701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus.
    Taraborelli M; Leuenberger L; Lazzaroni MG; Martinazzi N; Zhang W; Franceschini F; Salmon J; Tincani A; Erkan D
    Lupus; 2016 Oct; 25(12):1365-8. PubMed ID: 26945023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cardiac abnormalities in systemic lupus erythematosus and their association with antiphospholipid antibodies].
    Laganà B
    Recenti Prog Med; 1993 Oct; 84(10):662-72. PubMed ID: 8235032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus.
    Marchetti T; Ribi C; Perneger T; Trendelenburg M; Huynh-Do U; de Moerloose P; Chizzolini C
    Rheumatology (Oxford); 2018 Aug; 57(8):1350-1357. PubMed ID: 29672737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated levels of soluble CD40 ligand are associated with antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS
    Clin Exp Rheumatol; 2017; 35(5):823-830. PubMed ID: 28421990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
    Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
    Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome.
    Bertolaccini ML; Roch B; Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Br J Rheumatol; 1998 Nov; 37(11):1229-32. PubMed ID: 9851275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
    Annese V; Tomietto P; Venturini P; D'Agostini S; Ferraccioli G
    Reumatismo; 2006; 58(1):50-8. PubMed ID: 16639488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up study.
    Kampolis C; Tektonidou M; Moyssakis I; Tzelepis GE; Moutsopoulos H; Vlachoyiannopoulos PG
    Semin Arthritis Rheum; 2014 Feb; 43(4):558-65. PubMed ID: 24012042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
    Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
    Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
    Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Falcao CA; Alves IC; Chahade WH; Duarte AL; Lucena-Silva N
    Arq Bras Cardiol; 2002 Sep; 79(3):285-91. PubMed ID: 12386730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease.
    Jensen-Urstad K; Svenungsson E; de Faire U; Silveira A; Witztum JL; Hamsten A; Frostegård J
    Lupus; 2002; 11(11):744-52. PubMed ID: 12475005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes.
    Tanacan A; Beksac MS; Orgul G; Duru S; Sener B; Karaagaoglu E
    Hum Antibodies; 2019; 27(2):135-141. PubMed ID: 30856108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort.
    Magro-Checa C; Kumar S; Ramiro S; Beaart-van de Voorde LJ; Eikenboom J; Ronen I; de Bresser J; van Buchem MA; Huizinga TW; Steup-Beekman GM
    Lupus; 2019 Jan; 28(1):94-103. PubMed ID: 30526327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
    PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies.
    Watanabe T; Oku K; Amengual O; Hisada R; Ohmura K; Nakagawa I; Shida H; Bohgaki T; Horita T; Yasuda S; Atsumi T
    Lupus; 2018 Feb; 27(2):225-234. PubMed ID: 28659045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.